Additionally, another study done with Zerona Z6 received the FDA’s 510(k) market clearance for a ONCE a week protocol which resulted in 6.2 inch reduction for study participants over 6 weeks. Next, the Zerona Z6 was granted an “Over the Counter” indication by the FDA because of its safety in use AND most recently another FDA indication for “reduction of Overall Body Circumference”.

Zerona results have been proven through double-blind, randomized, multi-site and placebo-controlled clinical studies, in which study participants lost, on average, 3.64 inches from their waist, hips and thighs in 2 weeks in the first study and 3.72 inches in 2 weeks in the second study. These studies were verified by the U.S. Food and Drug Administration (FDA). The participants’ results were dramatic compared to the placebo group: placebo participants only lost an average of 1/2 an inch over the same time period when placebo treatments applied.